Category Archives: WHO
India at WTO: Takes strong stand to save generic drugs industry, calls for transparent health assessment
By Shreerupa Mitra-Jha, FirstPost | November 13, 2016 Governments engaged in bilateral and regional trade investments should ensure that these agreements do not include provisions that impinge on the right to health, and as a first step should undertake public health … Continue reading
By JASON CONE and RAYMOND C. OFFENHEISER, The New York Times|OCT. 27, 2016 Every few months, a drug company gets caught cranking up prices. Most recently, Mylan, the maker of EpiPen, took its turn in the hot seat for raising the … Continue reading
IP watch, December 9, 2015. From the United Nations Millennium Development Goals to the Sustainable Development Goals, what are the main achievements in health and what are the main challenges for the next 15 years? That is the question the … Continue reading
Third World Network, November 20, 2015. Geneva – A socioeconomic impact study on substandard/spurious/ falsely-labelled/falsified/counterfeit (SSFFC) medical products by the World Health Organization secretariat comes across as propaganda findings, according to several developing countries.
Third World Network, November 19, 2015. By KM Gopakumar. Geneva – The World Health Organization has proposed to join the intellectual property enforcement initiative of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund).
WHO; November 12; 2015. Geneva – In a speech at a meeting of global health policy think tanks WHO Director-General Margaret Chan addressed concerns about rising challenges in the global access to affordable pharmaceuticals. Talking about the sustainable development goals and their implications for … Continue reading
Trade, health, and intellectual property came together today as the heads of three specialised international organisations held an annual symposium to stimulate discussions on how the three can best help public health, and notably access to medicines in developing countries.